Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google Scholar citation report
Citations : 2035

Journal of Palliative Care & Medicine received 2035 citations as per Google Scholar report

Journal of Palliative Care & Medicine peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Treatment outcomes with tocilizumab in adult patients with severe and critical COVID-19 pneumonia of mariano marcos memorial hospital and medical center: A Retrospective Study

11th International Conference on Internal Medicine & Patient Care

Sheryll J. Pascual

Mariano Marcos Memorial Hospital & Medical Center, Philippines

ScientificTracks Abstracts: J Palliat Care Med

Abstract
Objectives: As SARS-Cov-2 infection leads to the development of cytokine storm syndrome, Tocilizumab, a biological agent that inhibits the cytokine interleukin 6, was seen to have clinical effects in COVID-19. Hematological markers used to determine clinical severity based on current literature revealed that ALC, CRP, Ferritin, LDH and D-dimer levels were associated with COVID severity. We aimed to determine the association of recovery and mortality rate with Tocilizumab based on inflammatory markers significant in COVID-19 infection such as CRP, LDH, D-dimer, Ferritin, Absolute Lymphocyte Count and associate comorbidities of patients to mortality. Methods: This was a single-center retrospective study which includes 101 t patients diagnosed with COVID-19 Severe and Critical Pneumonia. Independent Sample T-test, Mann-Whitney U test and Fisher�s Exact/Chi-square test was used. Odds ratio was computed to determine significant predictors for mortality. Results: Diabetic patients were 5.3 times more likely to and Chronic Kidney Disease was 18 times more likely to have mortality. For every unit increase in patient�s D-dimer and CRP during admission, the odds of mortality also increase by 0.02% and 0.73%, 0.01, unit decrease in patient�s Absolute 0.02,w Lymphocyte Count during admission, the odds of Mortality decrease by 17.86%. Every 0.01-unit increase in patient�s ABG PaO2/FiO2 during admission, the odds of mortality decrease by 10.1%. In patient�s D-dimer, Ferritin, CRP and LDH prior to discharge, every unit increase, the odds of mortality also increase by 0.03%, 0.18%, 2.29% and 0.58, respectively. Every 0.01-unit increase in patient�s ALC prior discharge, mortality decrease by 13.35%. Conclusion: Tocilizumab treatment was associated with reduction in the mortality of patient with Severe and Critical COVID Pneumonia in association with inflammatory markers, LDH, Ferritin, D-dimer and CRP, improvement of ABG PaO2/FIO2 and decreased infiltrates by chest x-ray. Mortality from COVID-19 Pneumonia was associated with CKD, DMT2, and HCVD Recent Publications Manalo, G., Lu-Reyes, J., Carabbacan C., Santos, M., Pascual, S. Therapeutic Plasma Exchange as a Treatment for Central Pontine Myelinolysis in a 41 year old Male with Chronic Renal Insufficiency: A Case Report; Philippine Journal of Internal Medicine (Volume 60 No. 4)
Biography

Sheryll J.Pascual MD in Internal Medicine Physician at Mariano Marcos Memorial Hospital and Medical Center, Philippines. She finished her residency training in internal medicine last December 2022 and Currently Medical Officer on the said institution.

Relevant Topics
Top